Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $303.4 million versus the consensus estimate of $292.91 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.